Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Allergic and Noninvasive Infectious Pulmonary Aspergillosis Syndromes.

Muldoon EG, Strek ME, Patterson KC.

Clin Chest Med. 2017 Sep;38(3):521-534. doi: 10.1016/j.ccm.2017.04.012. Epub 2017 Jun 12. Review.

PMID:
28797493
2.

First isolation of the pan-azole-resistant Aspergillus fumigatus cyp51A TR46/Y121F/T289A mutant in a UK patient.

Moore CB, Novak-Frazer L, Muldoon E, Dunn KW, Masania R, Richardson MD, Rautemaa-Richardson R.

Int J Antimicrob Agents. 2017 Apr;49(4):512-514. doi: 10.1016/j.ijantimicag.2017.01.004. Epub 2017 Feb 9. No abstract available.

PMID:
28193463
3.

Delivering on Antimicrobial Resistance Agenda Not Possible without Improving Fungal Diagnostic Capabilities.

Denning DW, Perlin DS, Muldoon EG, Colombo AL, Chakrabarti A, Richardson MD, Sorrell TC.

Emerg Infect Dis. 2017 Feb;23(2):177-183. doi: 10.3201/eid2302.152042. Epub 2017 Feb 15.

4.

Challenges in the management of chronic pulmonary aspergillosis.

Kosmidis C, Muldoon EG.

Med Mycol. 2017 Jan 1;55(1):63-68. Epub 2016 Dec 2. Review.

PMID:
27915300
5.

Chronic fibrosing pulmonary aspergillosis: a cause of 'destroyed lung' syndrome.

Kosmidis C, Newton P, Muldoon EG, Denning DW.

Infect Dis (Lond). 2017 Apr;49(4):296-301. doi: 10.1080/23744235.2016.1232861. Epub 2016 Sep 23.

PMID:
27658458
6.

Aspergillus nodules; another presentation of Chronic Pulmonary Aspergillosis.

Muldoon EG, Sharman A, Page I, Bishop P, Denning DW.

BMC Pulm Med. 2016 Aug 18;16(1):123. doi: 10.1186/s12890-016-0276-3.

7.

Characterisation of fatigue and its substantial impact on health status in a large cohort of patients with chronic pulmonary aspergillosis (CPA).

Al-Shair K, Muldoon EG, Morris J, Atherton GT, Kosmidis C, Denning DW.

Respir Med. 2016 May;114:117-22. doi: 10.1016/j.rmed.2016.03.020. Epub 2016 Apr 2.

PMID:
27109821
8.

Secondary syphilis presenting with aortitis and coronary ostial occlusion.

Chadwick JA, MacNab A, Sarma J, Ray S, Kadir I, Muldoon EG.

Sex Transm Infect. 2016 Mar;92(2):108-9. doi: 10.1136/sextrans-2015-052247. Epub 2015 Dec 15.

PMID:
26670911
9.

A national survey of infectious disease practitioners on their use of outpatient parenteral antimicrobial therapy (OPAT).

Muldoon EG, Switkowski K, Tice A, Snydman DR, Allison GM.

Infect Dis (Lond). 2015 Jan;47(1):39-45. doi: 10.3109/00365548.2014.967290. Epub 2014 Nov 21.

PMID:
25415655
10.

Acidovorax oryzae catheter-associated bloodstream infection.

Orsborne C, Hardy A, Isalska B, Williams SG, Muldoon EG.

J Clin Microbiol. 2014 Dec;52(12):4421-4. doi: 10.1128/JCM.00657-14. Epub 2014 Oct 1.

11.

Editorial commentary: Prophylactic echinocandin: is there a subgroup of intensive care unit patients who benefit?

Muldoon EG, Denning DW.

Clin Infect Dis. 2014 May;58(9):1227-9. doi: 10.1093/cid/ciu080. Epub 2014 Feb 18. No abstract available.

PMID:
24550375
12.

Prediction model for 30-day hospital readmissions among patients discharged receiving outpatient parenteral antibiotic therapy.

Allison GM, Muldoon EG, Kent DM, Paulus JK, Ruthazer R, Ren A, Snydman DR.

Clin Infect Dis. 2014 Mar;58(6):812-9. doi: 10.1093/cid/cit920. Epub 2013 Dec 19. Erratum in: Clin Infect Dis. 2014 Jun;58(11):1647.

13.

The impact of cefepime as first line therapy for neutropenic fever on Clostridium difficile rates among hematology and oncology patients.

Muldoon EG, Epstein L, Logvinenko T, Murray S, Doron SI, Snydman DR.

Anaerobe. 2013 Dec;24:79-81. doi: 10.1016/j.anaerobe.2013.10.001. Epub 2013 Oct 15.

14.

Two-stage arthroplasty for prosthetic joint infection: a systematic review of acute kidney injury, systemic toxicity and infection control.

Luu A, Syed F, Raman G, Bhalla A, Muldoon E, Hadley S, Smith E, Rao M.

J Arthroplasty. 2013 Oct;28(9):1490-8.e1. doi: 10.1016/j.arth.2013.02.035. Epub 2013 Apr 8. Review.

PMID:
23578491
15.

Are we ready for an outpatient parenteral antimicrobial therapy bundle? A critical appraisal of the evidence.

Muldoon EG, Snydman DR, Penland EC, Allison GM.

Clin Infect Dis. 2013 Aug;57(3):419-24. doi: 10.1093/cid/cit211. Epub 2013 Apr 9. Erratum in: Clin Infect Dis. 2014 Mar;58(5):754.

16.

Treponema pallidum azithromycin resistance in Dublin, Ireland.

Muldoon EG, Walsh A, Crowley B, Mulcahy F.

Sex Transm Dis. 2012 Oct;39(10):784-6.

PMID:
23001265
17.

Cerebrospinal fluid HIV viral load may be detectable, despite serum viral load being undetectable, in patients diagnosed with syphilis.

Muldoon EG, Coughlan S, Mulcahy F.

Sex Transm Infect. 2012 Nov;88(7):480. doi: 10.1136/sextrans-2012-050549. Epub 2012 Jun 7. No abstract available.

PMID:
22679100
18.

Syphilis consequences and implications in delayed diagnosis: five cases of secondary syphilis presenting with ocular symptoms.

Muldoon EG, Hogan A, Kilmartin D, McNally C, Bergin C.

Sex Transm Infect. 2010 Dec;86(7):512-3. doi: 10.1136/sti.2009.041863. Epub 2010 Nov 8.

PMID:
21059839
19.

Varicella infection and the impact of late entry into the Irish healthcare system.

Feeney S, Muldoon E, Barrett P, Martos R, Mulvihill N, O'Flanagan D, Bergin C.

J Infect Public Health. 2010;3(3):106-12. doi: 10.1016/j.jiph.2010.07.001. Epub 2010 Aug 23. Review.

20.

Management of antiretroviral drug toxicity.

Feeney E, Muldoon E, Powderly WG.

Curr Opin HIV AIDS. 2006 Sep;1(5):430-6. doi: 10.1097/01.COH.0000239856.45485.db.

PMID:
19372843

Supplemental Content

Loading ...
Support Center